文献速递免疫规划传染病防控与疫情报告

幼儿接种MenACWY-TT疫苗后杀菌抗体持久性:临床研究综述

Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies.
PubMed 文献 · Vaccine · 2020-05-07

本综述汇总1项3期和3项2期开放标签随机临床研究,评估幼儿期接种MenACWY-TT后长期抗体持久性。初种后抗体应答持续约2-3年,至5年时下降,但各血清群几何平均滴度至5年仍升高;初种后4-5年加强接种,各血清群>99%受试者产生抗体应答,加强后2-6年抗体持久性下降幅度小。

要点

  • 幼儿初种MenACWY-TT后抗体应答持续约2-3年,至5年时下降。
  • 初种后4-5年加强接种,>99%受试者各血清群产生抗体应答。
  • 加强后2-6年抗体持久性下降幅度小,免疫记忆至少维持至青春期早期。

核心结论

  • 幼儿期初种MenACWY-TT后抗体应答持续约2-3年。
  • 初种后4-5年加强接种,抗体应答持续至加强后6年,提示免疫记忆至少维持至青春期早期。

研究设计与样本

  • 综述汇总1项3期和3项2期开放标签随机临床研究,评估幼儿接种MenACWY-TT后的长期抗体持久性。

主要发现

  • 初种后抗体应答持续约2-3年,然后至接种后5年下降。
  • 各血清群几何平均滴度至初种后5年仍升高。
  • 初种后4-5年加强接种,各血清群>99%受试者产生抗体应答,加强后2-6年抗体持久性下降幅度小。
  • 初种和加强后,MenACWY-TT与MenC疫苗受试者的MenC抗体应答持久性相似。

临床怎么用

  • 幼儿期接种MenACWY-TT后,可在4-5年时考虑加强接种以维持抗体应答。
  • 加强接种后抗体持久性可达6年,支持免疫记忆至少维持至青春期早期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The long-term persistence of antibody responses following primary vaccination with quadrivalent conjugate vaccines targeting meningococcal serogroups A, C, W, and Y (MenACWY) and the duration of protection following a booster dose have not been fully elucidated, particularly in children who received primary dosing as toddlers. This review summarizes the findings of one phase 3 and three phase 2 open-label, randomized clinical studies that assessed the long-term antibody persistence of MenACWY conjugated to tetanus toxoid as a carrier protein (MenACWY-TT) in toddlers. Following primary vaccination, antibody responses persisted for approximately 2-3 years and then decreased up to 5 years after vaccination. Geometric mean titers remained elevated for all serogroups up to 5 years after primary vaccination. In children who received a booster dose of MenACWY-TT at 4-5 years after primary dosing as toddlers, antibody responses were documented in >99% of subjects across all serogroups, with minimal decreases in antibody persistence from 2-6 years after booster vaccination. The persistence of meningococcal serogroup C (MenC) antibody responses was similar between MenACWY-TT and MenC vaccine recipients after primary and booster dosing. Together, these findings indicate that antibody responses to primary MenACWY-TT vaccination persist for 2-3 years. Additionally, these findings indicate that in subjects who receive primary MenACWY-TT vaccination as toddlers, the antibody response to booster MenACWY-TT vaccination lasts for up to 6 years and suggest that immune memory is afforded at least into early adolescence, which is an age group at increased risk of invasive meningococcal disease.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Webber C, Peyrani P, Balmer P, et al. Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies. Vaccine. 2020. PMID: 32389497. doi:10.1016/j.vaccine.2020.02.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。